A detailed history of Dakota Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dakota Wealth Management holds 54,521 shares of BMY stock, worth $3.15 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
54,521
Previous 56,165 2.93%
Holding current value
$3.15 Million
Previous $2.33 Million 20.97%
% of portfolio
0.06%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$39.66 - $51.75 $65,201 - $85,077
-1,644 Reduced 2.93%
54,521 $2.82 Million
Q2 2024

Jul 19, 2024

BUY
$40.25 - $52.99 $392,357 - $516,546
9,748 Added 21.0%
56,165 $2.33 Million
Q1 2024

Apr 24, 2024

BUY
$47.98 - $54.4 $1.3 Million - $1.48 Million
27,158 Added 141.01%
46,417 $2.52 Million
Q4 2023

Jan 30, 2024

SELL
$48.48 - $57.85 $221,117 - $263,853
-4,561 Reduced 19.15%
19,259 $988,000
Q3 2023

Oct 23, 2023

SELL
$57.89 - $64.73 $197,868 - $221,247
-3,418 Reduced 12.55%
23,820 $1.38 Million
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $45,425 - $50,437
713 Added 2.69%
27,238 $1.74 Million
Q1 2023

Apr 14, 2023

SELL
$65.71 - $74.53 $353,191 - $400,598
-5,375 Reduced 16.85%
26,525 $1.84 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $598,104 - $708,240
-8,734 Reduced 21.49%
31,900 $2.29 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $2,499 - $1.48 Million
19,225 Added 89.8%
40,634 $2.89 Million
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $1.23 Million - $1.35 Million
16,869 Added 371.56%
21,409 $1.65 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $279,119 - $334,688
4,540 New
4,540 $332,000
Q2 2021

Aug 02, 2021

SELL
$61.91 - $67.42 $704,969 - $767,711
-11,387 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$59.34 - $66.74 $18,870 - $21,223
-318 Reduced 2.72%
11,387 $719,000
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $675,846 - $765,858
11,705 New
11,705 $726,000
Q1 2019

Apr 18, 2019

SELL
$45.12 - $53.8 $251,318 - $299,666
-5,570 Closed
0 $0
Q4 2018

Jan 22, 2019

SELL
$48.76 - $63.23 $9,800 - $12,709
-201 Reduced 3.48%
5,570 $339,000
Q3 2018

Nov 07, 2018

BUY
$55.19 - $62.25 $19,647 - $22,161
356 Added 6.57%
5,771 $359,000
Q2 2018

Aug 09, 2018

BUY
$50.53 - $62.98 $273,619 - $341,036
5,415 New
5,415 $299,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dakota Wealth Management Portfolio

Follow Dakota Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.